- Home
- ICG vs CELU Comparison
ICG vs CELU Comparison
Compare ICG & CELU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICG
- CELU
- Stock Information
- Founded
- ICG 2017
- CELU 2016
- Country
- ICG China
- CELU United States
- Employees
- ICG N/A
- CELU N/A
- Industry
- ICG Semiconductors
- CELU Biotechnology: Pharmaceutical Preparations
- Sector
- ICG Technology
- CELU Health Care
- Exchange
- ICG Nasdaq
- CELU Nasdaq
- Market Cap
- ICG 67.3M
- CELU 56.9M
- IPO Year
- ICG 2023
- CELU N/A
- Fundamental
- Price
- ICG $1.38
- CELU $1.56
- Analyst Decision
- ICG Strong Buy
- CELU Strong Buy
- Analyst Count
- ICG 1
- CELU 1
- Target Price
- ICG $7.50
- CELU $6.00
- AVG Volume (30 Days)
- ICG 420.3K
- CELU 65.0K
- Earning Date
- ICG 11-13-2025
- CELU 12-05-2025
- Dividend Yield
- ICG N/A
- CELU N/A
- EPS Growth
- ICG 94.43
- CELU N/A
- EPS
- ICG 0.21
- CELU N/A
- Revenue
- ICG $36,367,850.00
- CELU $40,578,000.00
- Revenue This Year
- ICG N/A
- CELU N/A
- Revenue Next Year
- ICG $64.55
- CELU $76.00
- P/E Ratio
- ICG $4.93
- CELU N/A
- Revenue Growth
- ICG 6.53
- CELU 4.45
- 52 Week Low
- ICG $0.93
- CELU $1.00
- 52 Week High
- ICG $12.04
- CELU $4.35
- Technical
- Relative Strength Index (RSI)
- ICG 55.15
- CELU 33.27
- Support Level
- ICG $0.93
- CELU $1.62
- Resistance Level
- ICG $1.18
- CELU $1.83
- Average True Range (ATR)
- ICG 0.15
- CELU 0.15
- MACD
- ICG 0.04
- CELU -0.01
- Stochastic Oscillator
- ICG 73.77
- CELU 10.20
About ICG Intchains Group Limited
Intchains Group Ltd provides integrated solutions consisting of high-performance ASIC chips and ancillary software and hardware for blockchain applications. Its ASIC chips are designed for several key blockchain algorithms including Blake2bsha3, sha512MD160, Cryptonight V4, Eaglesong, Blake2s and others. The company has built a proprietary technology platform named Xihe Platform, which allows the development of a wide range of ASIC chips with high efficiency and scalability. It designs its ASIC chips in-house, which enables it to leverage proprietary silicon data to deliver products reflecting the latest technological developments. Geographically, it operates in Mainland China, Hong Kong, and Other countries or regions.
About CELU Celularity Inc.
Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.